• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
AIDS Update 2010

See next edition:

AIDS Update 2011

AIDS Update 2010

9780073527611
308.64 zł
277.77 zł Save 30.87 zł Tax included
Lowest price within 30 days before promotion: 277.77 zł
Quantity
Product unavailable
Out of print

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
AIDS UPDATE 2010 presents a balanced review of current research and information on HIV infection, HIV disease, and AIDS. AIDS UPDATE 2010 places discussion within a biological, medical, and social framework, helping readers more fully understand this devastating pandemic.
Product Details
45987
9780073527611
9780073527611

Data sheet

Publication date
2010
Issue number
19
Cover
paperback
Pages count
528
Dimensions (mm)
185 x 231
Weight (g)
841
  • Contents

    About the Author iii

    A Quarter Century of AIDS and Counting:: A Humanitarian Crisis x

    AIDS UPDATE 2010 xix

    Preface xxi

    Introduction:: Histories of Global -Pandemics, AIDS, Its Place in History, Overview of HIV/AIDS, International AIDS Conferences and Means of Remembering-the AIDS Quilt, Candlelight Memorial, and World AIDS Day 1

    Three Words Echo around the World:: AIDS Crisis Worsens! 1

    History of Global Pandemics and Epidemics 1

    Fear, Ignorance, and Condemnation:: Who Is to Blame? 2

    Imagine a World without AIDS 2

    Overview of HIV/AIDS 4

    AIDS:: A Unique Disease 5

    AIDS:: A Cause of Death 5

    Another Anniversary 6

    Other Anniversaries 6

    International AIDS Conferences 6

    Means of Remembering 7

    The 26th Candlelight Memorial 9

    Walking to Change the Course of the HIV/AIDS Epidemic-United States 10

    Bicycle Riding to Change the Course of the HIV/AIDS Epidemic-United States 12

    World AIDS Day:: An International Day of Coordinated Action:: A Time to Recharge and Reconnect 12

    The World Health and UNAIDS Organizations 13

    The Future 13

    National AIDS Hotlines 15

    Useful Internet Addresses 15

    1 AIDS:: Defining the Disease and Finding Its Cause 18

    The New Millennium 18

    AIDS:: A Disease or a Syndrome? 19

    First Reaction to AIDS:: Denial 20

    What Causes AIDS? 20

    How Do CD4+ Cells Relate to HIV Infection and AIDS? 22

    The Centers for Disease Control and Prevention Reports 24

    Discovery of the AIDS Virus 24

    Defining the Illness:: AIDS and Surveillance 26

    Summary 28

    Review Questions 28

    2 What Causes AIDS:: Origin of the AIDS Virus 29

    The Cause of AIDS:: The Human Immunodeficiency Virus (HIV) 29

    Dissidents (AIDS Doesnt Exist or HIV Isnt the Cause) 33

    Evidence That HIV Causes AIDS 33

    Origin of HIV:: The AIDS Virus 37

    Summary on the Origin of HIV 43

    Summary 44

    Review Questions 44

    3 Biological Characteristics of the AIDS Virus 45

    Viruses Need a Host Cell in Order to Reproduce 45

    Viruses Are Parasites 45

    Viruses Specific to Cell Type 46

    Retroviruses 46

    Description of HIV; How It Attaches to a Host Cell and Buds Out of the Cell 46

    Human Immunodeficiency Virus (HIV):: Its Life Cycle 49

    The HIV Life Cycle 49

    How HIV Escapes the Infected Cell 53

    Basic Genetic Structure of Retroviral Genomes 53

    Genetic Revolution 58

    Formation of Genetic Recombination in HIV 58

    Distinct Genotypes (Subtypes/Clades) of HIV-1 Worldwide Based on ENV and GAG Proteins 59

    Summary 62

    Review Questions 62

    4 Anti-HIV Therapy 64

    Exciting Times for Antiretroviral Therapy 65

    Anti-HIV Therapy 65

    HIV Eradication Update-Is a Cure Possible? 69

    Antiretroviral Therapy (ART) Drugs with FDA Approval 69

    The HIV Medicine Chest:: ART Drugs Receiving FDA Approval 72

    FDA-Approved Nucleoside/Non-Nucleoside Analog Reverse Transcriptase Inhibitors and Protease Inhibitors 73

    Use of Non-Nucleoside Analog Reverse Transcriptase Inhibitors 75

    FDA-Approved Protease Inhibitors 75

    Entry Inhibitors and Problems 78

    Integrase Inhibitors 79

    Development and Selection of HIV Drug-Resistant Mutants 80

    Development of HIV Drug Resistance to Protease Inhibitors 81

    How Combination Drug Therapy Can Reduce the Chance of HIV Drug Resistance 84

    HIV Treatment Regimen Failure 86

    Viral Load:: Its Relationship to HIV Disease and AIDS 91

    Medical Complications Associated with Anti-HIV Drug Therapies (ART) 91

    Update 2010 96

    Novel Drugs 99

    Summary 102

    Disclaimer 104

    Some AIDS Therapy Information Hotlines 105

    Review Questions 105

    5 The Immunology of HIV Disease/AIDS 107

    The Immune System 107

    Human Lymphocytes:: T Cells and B Cells 109

    Why CD4+ Cells Are Important in HIV Infection-What It Means 114

    The CD4+ Cell Count-Why It Matters 114

    Antibodies and HIV Disease 118

    Cellular Micro-RNAs Contribute to HIV Latency in Resting Primary CD4+ T Cells 120

    Immune System Dysfunction 121

    Original Antigenic Sin 121

    The Search for Additional Receptors (Coreceptors) to CD4:: Fusin or CXCKR-4 (R-4) 124

    CCKR-5 (R-5) Receptor 124

    Emergence of HIV Strains That Vary in Their Lethal Abilities 124

    In Search of Genetic Resistance to HIV Infection 125

    T4 Cell Depletion and Immune Suppression 127

    Impact of T4 Cell Depletion 129

    Role of Monocytes and Macrophages in HIV Infection 129

    Where Do T4 or CD4+ Cells Become HIV Infected? 130

    Summary 133

    Review Questions 133

    6 Opportunistic Infections and Cancers Associated with HIV Disease/AIDS 134

    What Is an Opportunistic Disease? 134

    The Prevalence of Opportunistic Diseases 135

    Opportunistic Infections in HIV-Infected People 135

    TB:: The Leading Cause of Death among HIV-Positive People Worldwide 146

    Cancer or Malignancy in HIV/AIDS Patients 146

    Disclaimer 151

    Summary 151

    Review Questions 151

    7 A Profile of Biological Indicators for HIV Disease and Progression to AIDS 152

    What Is Known and What Is Missing from Our Understanding of HIV/AIDS 152

    HIV Disease Defined 153

    Stages of HIV Disease (without Drug Therapy) 157

    HIV Disease without Symptoms, with Symptoms, and AIDS 162

    Production of HIV-Specific Antibodies 163

    Prognostic Biological Markers Related to AIDS Progression 165

    HIV Infection of the Central Nervous System (CNS) 174

    Neuropathies in HIV Disease/AIDS Patients 175

    Pediatric Clinical Signs and Symptoms 175

    Summary 177

    Review Questions 177

    8 Epidemiology andTransmission of the Human Immunodeficiency Virus 178

    We Must Stop HIV Transmission Now! 180

    Epidemiology of HIV Infection 180

    Transmission of Two Strains of HIV (HIV-1/HIV-2) 181

    Is HIV Transmitted by Insects? 181

    HIV Transmission 183

    HIV Transmission in Family/Household Settings 184

    Noncasual Transmission 184

    Gay Men Putting Themselves at High Risk for HIV Infection 194

    Problem 200

    Injection-Drug Users and HIV Transmission 206

    United States:: Heterosexual Injection-Drug Use (IDU) 206

    Injection-Drug Use and HIV Infections in Other Countries 209

    Other Means of HIV Transmission 215

    Influence of Sexually Transmitted Diseases on HIV Transmission and Vice-Versa 215

    Pediatric Transmission 221

    Conclusion 224

    National AIDS Resources 224

    Summary 225

    Challenge Your Assumptions about the HIV Infected 225

    Review Questions 225

    9 Preventing the Transmission of HIV 227

    The AIDS Generation:: I Knew Everything about It, and I Still Got It! 228

    Prevention, Not Treatment, Is the Least Expensive and Most Effective Way to Stop the Spread of HIV/AIDS 228

    Global Prevention 229

    Antiretroviral Drugs Having an Impact on Prevention, but We Cant Treat Our Way out of This Pandemic 230

    Advancing HIV Prevention:: New Strategies for a Changing Epidemic 234

    Preventing the Transmission of HIV 236

    Sexual Risk Taking Depends on Sexual Activity 239

    New Rules to an Old Game:: Promoting Safer Sex-Nobody Has a Body to Die For! 241

    The Male Condom 244

    The Female Condom or Femidom (Vaginal Pouch) 250

    An Alternative to Condoms:: Vaginal Microbicides (MI-CRO-BA-CIDES) 254

    Injection-Drug Use (IDU) and HIV Transmission:: The Twin Epidemics 254

    HIV Prevention for Injection-Drug Users 255

    Lifting the Ban on the Use of Federal Funding to Support Needle Exchange Programs 257

    Prevention of Blood and Blood Product HIV Transmission 258

    Infection Control Procedures 258

    Sexual Partner Notification:: Disclosure 260

    The U.S. Federal Government Has Now Adopted Partner Notification as Its Cornerstone in Its Effort to Help Control the Spread of HIV 261

    The First Human Vaccine:: The Impact of Vaccines on Infectious Diseases 264

    HIV Vaccine Development and Its Role in Prevention 264

    Types of Experimental HIV Vaccines 268

    DNA Vaccine 270

    Problems in the Search for HIV Vaccine 270

    Update 2009, September-Breaking News:: HIV Vaccine Is Safe, Partly Effective 271

    Summary 272

    Review Questions 273

    10 Prevalence of HIV Infections, AIDS Cases, and Deaths among Select Groups in the United States and in Other Countries 274

    A Word about HIV/AIDS Data 275

    The Millennium:: Year 2010 279

    Formula for Estimating HIV Infections 282

    Behavioral Risk Groups and Statistical Evaluation 282

    September 18:: Annual National HIV/AIDS Aging Awareness Day 293

    Estimates of AIDS Cases and HIV Infection 294

    Newly Infected 295

    Shape of the HIV Pandemic:: United States 295

    Shape of AIDS Pandemic:: United States 300

    Estimates of Deaths and Years of Potential Life Lost Due to AIDS in the United States 302

    Different Nations/Countries Have Different Epidemics. Each Faces Its Own Reality 302

    Canadas Estimated HIV/AIDS Cases through 2009:: Population 33,310,000 303

    Mexicos Estimated HIV/AIDS Cases through 2009:: Population 110 Million 303

    United Kingdoms (UK) Estimated HIV/AIDS Cases through 2009:: Population 61 Million 303

    Global Prevalence and Impact of HIV/AIDS (See Table 10-7) 305

    Connected but Separate:: Each Country a Different Reality, Different Countries Similar Questions but Different Answers, Different Epidemics 307

    Workforce-South Africa:: Some Examples 310

    Education:: Teachers and Students-South Africa and Some Countries in Southern Africa 310

    Other HIV/AIDS Time Bombs in Asia:: India, China, and Russia 311

    Summary 315

    Review Questions 316

    11 Prevalence of HIV Infection and AIDS Cases among Women and Children 317

    HIV/AIDS Is Defining the Lives of Millions of Women 318

    Female Vulnerability 318

    Every Day a Tragedy 318

    Triple Jeopardy 318

    Annual International Womens Day-March 8 319

    Women:: AIDS and HIV Infections Worldwide 319

    Asia-Pacific Region, Over 5 Million HIV Positive:: 2009 320

    Women:: HIV-Positive and AIDS Cases-United States 320

    Childbearing Women 335

    Internet 336

    Pediatric HIV-Positive and AIDS Cases-United States:: A Fight We Can Win! 336

    Orphaned Children Due to HIV Infection and AIDS 337

    The Phenomenon of AIDS Orphans 339

    Summary 344

    Review Questions 345

    12 Prevalence of HIV Infection and AIDS among Young Adults, Ages 13 to 24 346

    Global HIV Infections in Young Adults 346

    Addressing the AIDS Pandemic among Young Adults 347

    How Large Is the Young Adult Population in the United States? 349

    HIV/AIDS Wont Affect Us! 350

    Estimate of HIV-Infected and AIDS Cases among Young Adults in the United States, Globally 350

    Summary 358

    Internet 358

    Other Useful Sources 358

    Review Questions 358

    13 Testing for Human Immunodeficiency Virus 359

    Determining the Presence of Antibody Produced When HIV Is Present 360

    Requests for HIV Testing 360

    Reasons for HIV Testing 361

    Laboratory Methods for Detecting HIV 362

    ELISA HIV Antibody Test 363

    Western Blot Assay 369

    New ELISA Antibody Testing and Viral Load Procedures Reveal Early Versus Late HIV Infection 373

    Rapid HIV Testing 375

    FDA Approves Two Home HIV Antibody Test Kits 378

    Some Screening and Confirmatory Tests for HIV 380

    Deciding Who Should Get an HIV Test and When 382

    Why Is HIV Test Information Necessary? 384

    Immigration and Travel Ban into the United States Is Lifted 384

    Testing, Privacy, Competency, and Informed Consent 385

    Summary 393

    Review Questions 394

    14 AIDS and Society:: Knowledge, Attitudes, and Behavior 395

    HIV/AIDS Is a Story in Our Lifetime 396

    The New Millennium and HIV/AIDS 397

    HIV/AIDS Is an Unusual Social Disease 397

    Discrimination vs. Compassion and Support 397

    HIV/AIDS Is Here to Stay 398

    AIDS Comes to the United States 399

    Blame Someone, DŽjˆ Vu 399

    Fear:: Panic and Hysteria over the Spread of HIV/AIDS in the United States 400

    Whom Is the General Public to Believe? 402

    AIDS Education and Behavior::Dissipating Fear with Education 406

    The Character of Society 413

    Dealing with Discrimination:: The Americans with Disabilities Act 418

    Federal and Private Sector Financing:: Creation of an AIDS Industry 420

    U.S. Government Believes HIV/AIDS Is a Threat to National Security 424

    Global HIV/AIDS Funding for Underdeveloped Nations 428

    Forms of U.S. Monetary Assistance for HIV/AIDS 431

    Summary 438

    Review Questions 439

    Answers to Review Questions 440

    Glossary 446

    References 454

    Index 476

See next edition:

AIDS Update 2011
Comments (0)